Pharmafile Logo

Top 100 Creative Companies

We let your whole self shine

People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...

Lucid Group Communications Limited

EU flag

EMA proposes EU clinical trial reforms

The ACT EU paper provides a list of regulatory network objectives, priorities and governance strategies for 2022-2023

Anthem PR appoints new managing director Rebecca Fergusson

Fergusson previously held senior leadership positions at Mind + Matter and Red Health

image of scales

Hybrid working: Insights and tips for success

Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success

Porterhouse Medical Group

- PMLiVE

AstraZeneca’s Enhertu receives FDA grant for priority review

The approval is based on results from the DESTINY-Breast03 trial which showed a significant risk reduction of unresectable or metastatic HER-2 positive breast cancer progression

- PMLiVE

Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis

The FDA based its approval on results from a clinical trial programme involving over 1,600 patients

- PMLiVE

Vir Biotech launches new research programme for HIV and malaria prevention

Using antibody research, Vir will combine its existing immunology and virology expertise with the Gates Foundation

- PMLiVE

BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System

Following a successful development and testing programme, the computational system is able to predict high-risk variants of SARS-CoV-2

- PMLiVE

After the wildfire: how will healthcare recover from the pandemic?

After a forest fire, the natural world recovers according to predictable patterns, in a process known as ‘ecological succession’. The modern world has never seen a global conflagration quite like...

The New Normal: Upcoming Trends in Clinical Trials

Samuel Searcy, Founder & CEO of CliniStart, shares his expert insights into trends, current gaps, and future predictions for clinical trials. Among many other things, we also dive into his...

Impetus Digital

- PMLiVE

AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants

New data from continued testing has shown that a third booster of Vaxzevria supports an increased antibody response against SARS-CoV-2 variants

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links